We are live on ! Find out more
DARE icon

Dare Bioscience
DARE

15 hedge funds and large institutions have $864K invested in Dare Bioscience in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

7% more funds holding

Funds holding: 14 → 15 (+1)

0.06% more ownership

Funds ownership: 0.67% → 0.73% (+0.06%)

17% less capital invested

Capital invested by funds: $1.04M → $864K (-$181K)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
7
Increased
2
Reduced
1
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$66.7K
2
BFM
Boothbay Fund Management
New York
+$59.6K
3
PAM
Panagora Asset Management
Massachusetts
+$56.2K
4
Barclays
Barclays
United Kingdom
+$27K
5
Renaissance Technologies
Renaissance Technologies
New York
+$26.9K

Top Sellers

Rank Fund Capital Flow
1
RSCM
Rock Springs Capital Management
Maryland
-$135K
2
Goldman Sachs
Goldman Sachs
New York
-$25K
3
Citadel Advisors
Citadel Advisors
Florida
-$24K
4
UBS Group
UBS Group
Switzerland
-$6.27K
5
II
Inspire Investing
Idaho
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
1
CVI Holdings
Delaware
$395K +$795K +39,305 New
PVMCV
2
Polaris Venture Management Co V
Massachusetts
$273K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$61K +$22.5K +1,114 +22%
PAM
4
Panagora Asset Management
Massachusetts
$33K +$56.2K +2,779 +571%
VF
5
Virtu Financial
New York
$33K +$66.7K +3,300 New
BFM
6
Boothbay Fund Management
New York
$30K +$59.6K +2,946 New
Renaissance Technologies
7
Renaissance Technologies
New York
$13K +$26.9K +1,329 New
Barclays
8
Barclays
United Kingdom
$13K +$27K +1,333 New
TSS
9
Two Sigma Securities
New York
$11K +$22.9K +1,133 New
BlackRock
10
BlackRock
New York
$1K – – –
AWA
11
Artemis Wealth Advisors
New York
$738 – – –
RSCM
12
Rock Springs Capital Management
Maryland
– -$135K -5,208 Closed
Goldman Sachs
13
Goldman Sachs
New York
– -$25K -956 Closed
Citadel Advisors
14
Citadel Advisors
Florida
– -$24K -940 Closed
UBS Group
15
UBS Group
Switzerland
– -$6.27K -310 -88%
II
16
Inspire Investing
Idaho
– -$1K -34 Closed
PNC Financial Services Group
17
PNC Financial Services Group
Pennsylvania
– +$81 +4 New

DARE Hedge Fund Activity: Q1 2018 in Review

15 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q1 2018, worth a combined $864K — down 17% from $1.04M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new DARE positions and 6 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $66.7K. The largest seller was Rock Springs Capital Management, exiting entirely with an estimated $135K sold.

  • 15 institutional investors held Dare Bioscience (DARE) as of Q1 2018, up from 14 in Q4 2017.
  • Funds reported $864K of Dare Bioscience stock for Q1 2018, down 17% quarter-over-quarter.
  • 7 funds opened new Dare Bioscience positions in Q1 2018 and 6 closed out, a net change of +1 holder.
  • The largest Dare Bioscience buyer in Q1 2018 was Virtu Financial, an estimated $66.7K added.
  • The largest Dare Bioscience seller in Q1 2018 was Rock Springs Capital Management, an estimated $135K sold.

Based on aggregated 13F filings for Q1 2018.